resveratrol has been researched along with Myocardial Ischemia in 41 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (2.44) | 18.2507 |
2000's | 17 (41.46) | 29.6817 |
2010's | 19 (46.34) | 24.3611 |
2020's | 4 (9.76) | 2.80 |
Authors | Studies |
---|---|
Lu, J; Ma, Y; Sun, L; Wang, S; Xue, P; Yu, J; Yue, X; Zhang, Y | 1 |
Chen, H; Liu, H; Liu, S; Ren, J; Tang, L; Wang, X; Zhao, X; Zhou, T | 1 |
Guan, P; Ji, ES; Luo, LF; Qin, LY; Sun, ZM; Wang, N; Zhao, YS | 1 |
Bian, ZY; Ding, W; Feng, H; Li, WJ; Liao, HH; Mou, SQ; Zhang, N; Zhou, ZY | 1 |
Chen, HP; Deng, YZ; Li, XR; Liu, HY; Ma, ZX; Qiu, LJ; Xu, RY; Xu, XW; Zhao, L | 1 |
Dalal, RS; Elmadhun, NY; Robich, MP; Sabe, AA; Sellke, FW | 2 |
Das, DK; Das, S; Mitrovsky, G; Vasanthi, HR | 1 |
Bianchi, C; Dalal, RS; Elmadhun, NY; Robich, MP; Sabe, AA; Sadek, AA; Sellke, FW | 1 |
Cao, F; Chen, Y; Han, D; Ma, S; Wang, J | 1 |
Amadio, P; Banfi, C; Barbieri, SS; Brioschi, M; Colombo, GI; Gianellini, S; Ieraci, A; Lee, FS; Parolari, A; Tarantino, E; Tremoli, E; Werba, JP | 1 |
Chih, CL; Hu, BR; Huang, SS; Lin, JF; Lin, SM; Nien, MW; Su, HH; Tsai, SK | 1 |
Das, DK; Das, S; Dudley, J; Mukherjee, S | 1 |
Bertelli, AA; Das, DK; Das, M; Dudley, JI; Lekli, I; Mukherjee, S | 1 |
Cacciapuoti, F | 1 |
Chen, CJ; Fu, YC; Li, JL; Wang, W; Wang, X; Yu, W | 1 |
Bianchi, C; Sellke, FW; Wykrzykowska, JJ | 1 |
Chaudray, M; Chu, LM; Clements, RT; Coady, MA; Han, Y; Laham, RJ; Manning, WJ; Nezafat, R; Robich, MP; Sellke, FW | 1 |
Bernhagen, J; Bucala, R; Leng, L; Li, J; Ma, H; Merk, M; Ren, J; Thomas, DP; Tong, C; Wang, J; Wang, W; Zierow, S | 1 |
Bianchi, C; Boodhwani, M; Clements, RT; Coady, MA; Feng, J; Laham, RJ; Nezafat, R; Osipov, RM; Robich, MP; Sellke, FW | 1 |
Das, DK; Gesztelyi, R; Juhasz, A; Juhasz, B; Juhaz, B; Kertesz, A; Varga, B | 1 |
Ahsan, K; Bagchi, A; Das, DK; Mukherjee, S; Mukhopadhyay, P; Pacher, P | 1 |
Das, DK; Mukhopadhyay, P; Pacher, P | 1 |
Chu, LM; Clements, RT; Feng, J; Han, Y; Manning, WJ; Nezafat, R; Osipov, RM; Robich, MP; Sellke, FW | 1 |
Burgess, T; Chu, LM; Clements, RT; Feng, J; Laham, RJ; Lassaletta, AD; Robich, MP; Sellke, FW | 1 |
Ahsan, MK; Das, DK; Das, S; Mukhopadhyay, P; Otani, H | 1 |
Burgess, TA; Chu, LM; Feng, J; Han, Y; Laham, RJ; Leber, MP; Manning, WJ; Nezafat, R; Robich, MP; Sellke, FW | 1 |
Bin, J; Chen, B; Chen, C; Liao, Y; Wu, B; Xu, D; Xuan, W; Zhang, W | 1 |
Forini, F; Iervasi, G; Sabatino, L | 1 |
Barenghi, L; Beemster, P; Bertelli, AA; Bradamante, S; De Jong, JW; De Jonge, R; Piccinini, F | 2 |
Dernek, S; Ergun, B; Erkasap, N; Ikizler, M; Kaygisiz, Z; Koken, T; Kural, T; Sevin, B; Yilmaz, K | 1 |
Cingolani, HE; Fantinelli, JC; Mosca, SM; Schinella, G | 1 |
Akar, F; Aslamaci, S; Coskun, B; Kiziltepe, U; Rakici, O | 1 |
Bagchi, D; Das, DK; Das, S; Maulik, N; Tosaki, A | 1 |
Jia, GL; Ma, H; Shen, M; Wang, YM | 1 |
Bertelli, A; Bertelli, AA; Cordis, GA; Das, DK; Maulik, G; Ray, PS | 1 |
Bagchi, D; Das, DK; Maulik, G; Sato, M | 1 |
Chen, JK; Huang, SS; Hung, LM; Lee, RS; Su, MJ | 1 |
Chan, WF; Chen, JK; Chiao, CW; Chu, WK; Hung, LM; Su, MJ | 1 |
Das, DK; Hattori, R; Maulik, N; Otani, H | 1 |
4 review(s) available for resveratrol and Myocardial Ischemia
Article | Year |
---|---|
SIRT1 as a Promising Novel Therapeutic Target for Myocardial Ischemia Reperfusion Injury and Cardiometabolic Disease.
Topics: Animals; Apoptosis; Disease Models, Animal; Heterocyclic Compounds, 4 or More Rings; Humans; Metabolic Diseases; Molecular Targeted Therapy; Myocardial Ischemia; Myocardial Reperfusion Injury; Myocytes, Cardiac; Resveratrol; Sirtuin 1; Stilbenes; Transcriptional Activation | 2017 |
Opposite effects of metabolic syndrome and calorie restriction on thrombotic disease: heads and tails of the same coin--resveratrol's role.
Topics: Animals; Blood Coagulation; Caloric Restriction; Fibrinolytic Agents; Humans; Metabolic Syndrome; Myocardial Ischemia; Resveratrol; Sirtuins; Stilbenes; Thrombosis; Ventricular Function, Left; Wine | 2009 |
Impact of aging on the angiogenic potential of the myocardium: implications for angiogenic therapies with emphasis on sirtuin agonists.
Topics: Aging; Angiogenesis Inducing Agents; Angiogenesis Inhibitors; Animals; Collateral Circulation; Coronary Vessels; Humans; Myocardial Ischemia; Resveratrol; Sirtuins; Stilbenes | 2009 |
MicroRNA signatures of resveratrol in the ischemic heart.
Topics: Animals; Humans; MicroRNAs; Myocardial Ischemia; Resveratrol; Stilbenes | 2011 |
1 trial(s) available for resveratrol and Myocardial Ischemia
Article | Year |
---|---|
Effects of resveratrol on vascular tone and endothelial function of human saphenous vein and internal mammary artery.
Topics: Acetylcholine; Antioxidants; Coronary Artery Bypass; Endothelium, Vascular; Female; Follow-Up Studies; Humans; In Vitro Techniques; Indomethacin; Male; Mammary Arteries; Middle Aged; Myocardial Ischemia; Norepinephrine; Resveratrol; Saphenous Vein; Stilbenes; Vasoconstrictor Agents; Vasodilation; Vasodilator Agents | 2005 |
36 other study(ies) available for resveratrol and Myocardial Ischemia
Article | Year |
---|---|
Establishment of fingerprint and mechanism of anti-myocardial ischemic effect of Syringa pinnatifolia.
Topics: Animals; bcl-2-Associated X Protein; Caspase 3; Creatine Kinase; Eosine Yellowish-(YS); Flavonoids; Hematoxylin; Isoenzymes; Lactate Dehydrogenases; Myocardial Infarction; Myocardial Ischemia; Myocardium; Myocytes, Cardiac; Plant Extracts; Proto-Oncogene Proteins c-bcl-2; Rats; Resveratrol; Syringa; Terpenes | 2022 |
Resveratrol inhibits autophagy against myocardial ischemia-reperfusion injury through the DJ-1/MEKK1/JNK pathway.
Topics: Animals; Apoptosis; Autophagy; MAP Kinase Kinase Kinases; MAP Kinase Signaling System; Myocardial Ischemia; Myocardial Reperfusion Injury; Myocytes, Cardiac; Rats; Resveratrol | 2023 |
Resveratrol protects against CIH-induced myocardial injury by targeting Nrf2 and blocking NLRP3 inflammasome activation.
Topics: Animals; Antioxidants; Blotting, Western; Echocardiography; Fluorescent Antibody Technique; Hypoxia; Inflammasomes; Male; Myocardial Ischemia; NF-E2-Related Factor 2; NLR Family, Pyrin Domain-Containing 3 Protein; Oxidative Stress; Rats; Rats, Sprague-Dawley; Real-Time Polymerase Chain Reaction; Resveratrol | 2020 |
Resveratrol Inhibits Ischemia-Induced Myocardial Senescence Signals and NLRP3 Inflammasome Activation.
Topics: Animals; Apoptosis; Biomarkers; Cell Hypoxia; Heart Function Tests; Inflammasomes; Male; Mice, Inbred C57BL; Myocardial Ischemia; Myocardium; Myocytes, Cardiac; NLR Family, Pyrin Domain-Containing 3 Protein; Rats, Sprague-Dawley; Resveratrol; Risk Factors; Signal Transduction | 2020 |
Resveratrol attenuates myocardial hypoxia/reoxygenation-induced cell apoptosis through DJ-1-mediated SIRT1-p53 pathway.
Topics: Acetylation; Animals; Apoptosis; Cardiotonic Agents; Cell Hypoxia; Cell Line; Cell Survival; Enzyme Activation; L-Lactate Dehydrogenase; Myocardial Ischemia; Myocardial Reperfusion Injury; Protein Binding; Protein Deglycase DJ-1; Rats; Resveratrol; Sirtuin 1; Tumor Suppressor Protein p53 | 2019 |
Does resveratrol improve insulin signaling in chronically ischemic myocardium?
Topics: AMP-Activated Protein Kinases; Animals; Apoptosis; Cardiotonic Agents; Disease Models, Animal; Glucose; Insulin; Male; Metabolic Syndrome; Myocardial Ischemia; Myocardium; Resveratrol; Signal Transduction; Stilbenes; Swine | 2013 |
Resveratrol regulates autophagy signaling in chronically ischemic myocardium.
Topics: Animals; Apoptosis Regulatory Proteins; Autophagy; Blotting, Western; Cholesterol, Dietary; Diet, High-Fat; Disease Models, Animal; Lysosomal-Associated Membrane Protein 2; Male; Microtubule-Associated Proteins; Myocardial Ischemia; Myocardium; Phosphorylation; Resveratrol; Ribosomal Protein S6 Kinases, 70-kDa; Signal Transduction; Stilbenes; Swine; Swine, Miniature; Time Factors; TOR Serine-Threonine Kinases | 2014 |
Antiaging properties of a grape-derived antioxidant are regulated by mitochondrial balance of fusion and fission leading to mitophagy triggered by a signaling network of Sirt1-Sirt3-Foxo3-PINK1-PARKIN.
Topics: Aging; Animals; Antioxidants; Apoptosis; Blotting, Western; Fluorescent Antibody Technique; Forkhead Box Protein O3; Forkhead Transcription Factors; Glutathione; Heart Ventricles; In Vitro Techniques; Intracellular Space; Male; Mitochondrial Dynamics; Mitophagy; Myocardial Infarction; Myocardial Ischemia; Myocardium; Myocytes, Cardiac; Protein Kinases; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Resveratrol; Signal Transduction; Sirtuins; Stilbenes; Ubiquitin-Protein Ligases; Vitis | 2014 |
Investigating the effects of resveratrol on chronically ischemic myocardium in a swine model of metabolic syndrome: a proteomics analysis.
Topics: Animals; Antioxidants; Biomarkers; Cell Death; Cholesterol, Dietary; Coronary Vessels; Dietary Supplements; Disease Models, Animal; Heart; Male; Metabolic Syndrome; Mitochondria; Myocardial Ischemia; Myocardium; Phytotherapy; Plant Extracts; Proteins; Proteomics; Resveratrol; Signal Transduction; Stilbenes; Swine | 2015 |
BDNFVal66met polymorphism: a potential bridge between depression and thrombosis.
Topics: Animals; Anxiety Disorders; Aorta; Blood Coagulation; Brain-Derived Neurotrophic Factor; Carotid Arteries; Carotid Artery Thrombosis; Depressive Disorder; Disease Models, Animal; Female; Heterozygote; Homozygote; Humans; Male; Mice, Transgenic; Middle Aged; Myocardial Ischemia; Nerve Tissue Proteins; Platelet Activation; Platelet Aggregation Inhibitors; Polymorphism, Single Nucleotide; Receptors, Cell Surface; Resveratrol; Signal Transduction; Sirtuin 1; Stilbenes; Thrombosis | 2017 |
Resveratrol reduces infarct size and improves ventricular function after myocardial ischemia in rats.
Topics: Animals; Antioxidants; Atrial Natriuretic Factor; Collagen Type I; Echocardiography; Hemodynamics; Male; Mice; Myocardial Ischemia; Random Allocation; Rats; Rats, Sprague-Dawley; Resveratrol; Stilbenes; Transforming Growth Factor beta1; Ventricular Remodeling | 2008 |
Resveratrol, a unique phytoalexin present in red wine, delivers either survival signal or death signal to the ischemic myocardium depending on dose.
Topics: Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Cell Survival; Dose-Response Relationship, Drug; Down-Regulation; Male; Myocardial Ischemia; NF-kappa B; Oxidation-Reduction; Phytoalexins; Rats; Rats, Sprague-Dawley; Resveratrol; Sesquiterpenes; Signal Transduction; Stilbenes; Terpenes; Wine | 2009 |
Does white wine qualify for French paradox? Comparison of the cardioprotective effects of red and white wines and their constituents: resveratrol, tyrosol, and hydroxytyrosol.
Topics: Animals; Apoptosis; Apoptosis Regulatory Proteins; Cardiotonic Agents; Heart; Humans; In Vitro Techniques; Male; Mitochondrial Swelling; Myocardial Ischemia; Myocardium; Peroxides; Phenylethyl Alcohol; Random Allocation; Rats; Rats, Sprague-Dawley; Resveratrol; Stilbenes; Wine | 2008 |
Resveratrol protects cardiomyocytes from hypoxia-induced apoptosis through the SIRT1-FoxO1 pathway.
Topics: Animals; Antioxidants; Apoptosis; Cell Hypoxia; Cells, Cultured; Cytoprotection; Forkhead Transcription Factors; Myocardial Ischemia; Myocytes, Cardiac; Nerve Tissue Proteins; Rats; Resveratrol; Sirtuin 1; Sirtuins; Stilbenes | 2009 |
Anti-angiogenic effect of high-dose resveratrol in a swine model of metabolic syndrome.
Topics: Angiogenesis Inhibitors; Angiostatins; Animals; Antigens, CD; Cadherins; Cholesterol, Dietary; Collateral Circulation; Coronary Angiography; Disease Models, Animal; Magnetic Resonance Imaging; Male; Metabolic Syndrome; Myocardial Ischemia; Neovascularization, Physiologic; Resveratrol; Stilbenes; Swine; Swine, Miniature | 2010 |
Impaired macrophage migration inhibitory factor-AMP-activated protein kinase activation and ischemic recovery in the senescent heart.
Topics: Aging; AMP-Activated Protein Kinases; Animals; Down-Regulation; Enzyme Inhibitors; Hypoxia-Inducible Factor 1, alpha Subunit; Intramolecular Oxidoreductases; Macrophage Migration-Inhibitory Factors; Mice; Mice, Knockout; Myocardial Infarction; Myocardial Ischemia; Myocardium; Myocytes, Cardiac; Phenotype; Phosphorylation; Resveratrol; Signal Transduction; Stilbenes; Ultrasonography; Ventricular Function, Left | 2010 |
Resveratrol improves myocardial perfusion in a swine model of hypercholesterolemia and chronic myocardial ischemia.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Capillaries; Chronic Disease; Coronary Circulation; Coronary Disease; Disease Models, Animal; Female; Humans; Hypercholesterolemia; Male; Microcirculation; Myocardial Ischemia; Myocardium; Neovascularization, Physiologic; Perfusion; Resveratrol; Signal Transduction; Stilbenes; Swine; Vascular Endothelial Growth Factor A | 2010 |
Reduction of blood cholesterol and ischemic injury in the hypercholesteromic rabbits with modified resveratrol, longevinex. [corrected]
Topics: Animals; Anticholesteremic Agents; Arteriosclerosis; Biomarkers; Cholesterol; Disease Models, Animal; Down-Regulation; Hemodynamics; Hypercholesterolemia; Male; Myocardial Infarction; Myocardial Ischemia; Myocardial Reperfusion Injury; Myocardium; Rabbits; Resveratrol; Stilbenes; Time Factors; Ventricular Function, Left; Ventricular Pressure | 2011 |
Restoration of altered microRNA expression in the ischemic heart with resveratrol.
Topics: Animals; Cardiotonic Agents; Computational Biology; Heart; Male; Mice; MicroRNAs; Myocardial Ischemia; Rats; Rats, Sprague-Dawley; Reperfusion Injury; Resveratrol; Reverse Transcriptase Polymerase Chain Reaction; Software; Stilbenes | 2010 |
Resveratrol modifies risk factors for coronary artery disease in swine with metabolic syndrome and myocardial ischemia.
Topics: Animals; Biomarkers; Cholesterol; Coronary Artery Disease; Diet; Dietary Supplements; Fatty Acids, Nonesterified; Gene Expression Regulation; Glucose Tolerance Test; Glucose Transporter Type 4; Heart; Inflammation; Insulin; Magnetic Resonance Imaging; Metabolic Syndrome; Microvessels; Muscle Cells; Myocardial Ischemia; Oxidation-Reduction; Protein Transport; Resveratrol; Risk Factors; Stilbenes; Swine | 2011 |
Resveratrol supplementation abrogates pro-arteriogenic effects of intramyocardial vascular endothelial growth factor in a hypercholesterolemic swine model of chronic ischemia.
Topics: Administration, Oral; Animals; Blood Chemical Analysis; Coronary Angiography; Coronary Circulation; Disease Models, Animal; Drug Therapy, Combination; Hypercholesterolemia; Immunoblotting; Immunohistochemistry; Male; Myocardial Ischemia; Neovascularization, Physiologic; Oxidative Stress; Phosphorylation; Random Allocation; Reference Values; Resveratrol; Risk Factors; Sensitivity and Specificity; Stilbenes; Swine; Vascular Endothelial Growth Factor A | 2011 |
Modulation of microRNA 20b with resveratrol and longevinex is linked with their potent anti-angiogenic action in the ischaemic myocardium and synergestic effects of resveratrol and γ-tocotrienol.
Topics: Angiogenesis Inhibitors; Animals; Apoptosis; Chromans; Down-Regulation; Drug Synergism; Gene Expression Profiling; Heart; Hypoxia-Inducible Factor 1, alpha Subunit; Male; MicroRNAs; Microscopy, Confocal; Multivariate Analysis; Myocardial Ischemia; Myocardium; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Resveratrol; Signal Transduction; Stilbenes; Vascular Endothelial Growth Factor A; Vitamin E | 2012 |
Resveratrol preserves myocardial function and perfusion in remote nonischemic myocardium in a swine model of metabolic syndrome.
Topics: Animals; Antioxidants; Biomarkers; Blotting, Western; Coronary Vessels; Diet, High-Fat; Disease Models, Animal; Fluorescent Antibody Technique; Heart; Magnetic Resonance Imaging; Metabolic Syndrome; Myocardial Ischemia; Myocardium; Oxidative Stress; Resveratrol; Stilbenes; Swine; Ventricular Function, Left | 2012 |
Resveratrol improves myocardial ischemia and ischemic heart failure in mice by antagonizing the detrimental effects of fractalkine*.
Topics: Animals; Animals, Newborn; Chemokine CX3CL1; Disease Models, Animal; Electrocardiography; Heart Failure; Male; Mice; Mice, Inbred C57BL; Myocardial Ischemia; Platelet Aggregation Inhibitors; Random Allocation; Rats; Resveratrol; Stilbenes; Ventricular Remodeling | 2012 |
A glass of wine: how good is good? The resveratrol lesson*.
Topics: Animals; Chemokine CX3CL1; Heart Failure; Male; Myocardial Ischemia; Platelet Aggregation Inhibitors; Resveratrol; Stilbenes | 2012 |
Resveratrol provides late-phase cardioprotection by means of a nitric oxide- and adenosine-mediated mechanism.
Topics: Adenosine; Animals; Cardiotonic Agents; Coronary Circulation; Enzyme Inhibitors; Heart; In Vitro Techniques; Male; Myocardial Ischemia; Myocardial Reperfusion Injury; Myocardium; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Purinergic P1 Receptor Antagonists; Rats; Rats, Sprague-Dawley; Resveratrol; Stilbenes; Theophylline; Time Factors; Vasodilator Agents | 2003 |
Cardioprotection with resveratrol pretreatment: improved beneficial effects over standard treatment in rat hearts after global ischemia.
Topics: Analysis of Variance; Animals; Coronary Circulation; Disease Models, Animal; Hemodynamics; Ischemic Preconditioning, Myocardial; Male; Myocardial Ischemia; Myocardial Reperfusion; Myocardial Reperfusion Injury; Probability; Random Allocation; Rats; Rats, Sprague-Dawley; Resveratrol; Sensitivity and Specificity; Stilbenes; Survival Rate | 2004 |
Effects of different fractions of a red wine non-alcoholic extract on ischemia-reperfusion injury.
Topics: Animals; Argentina; Blood Pressure; Cardiotonic Agents; Flavonols; L-Lactate Dehydrogenase; Lipid Peroxidation; Male; Myocardial Ischemia; Myocardial Reperfusion Injury; Phenols; Rats; Rats, Wistar; Resveratrol; Stilbenes; Thiobarbituric Acid Reactive Substances; Ventricular Function, Left; Wine | 2005 |
Potentiation of a survival signal in the ischemic heart by resveratrol through p38 mitogen-activated protein kinase/mitogen- and stress-activated protein kinase 1/cAMP response element-binding protein signaling.
Topics: Animals; Cardiotonic Agents; Cyclic AMP Response Element-Binding Protein; Enzyme Inhibitors; In Vitro Techniques; Male; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 8; Mitogen-Activated Protein Kinases; Myocardial Infarction; Myocardial Ischemia; Myocardium; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Rats; Rats, Sprague-Dawley; Resveratrol; Signal Transduction; Stilbenes | 2006 |
Cardioprotective effect of resvaratrol pretreatment on myocardial ischemia-reperfusion induced injury in rats.
Topics: Animals; Antioxidants; Cardiotonic Agents; Free Radical Scavengers; Male; Myocardial Ischemia; Myocardial Reperfusion Injury; Nitric Oxide; Rats; Rats, Sprague-Dawley; Resveratrol; Stilbenes; Up-Regulation | 2006 |
The red wine antioxidant resveratrol protects isolated rat hearts from ischemia reperfusion injury.
Topics: Animals; Antioxidants; Free Radicals; Heart; In Vitro Techniques; Male; Malondialdehyde; Myocardial Infarction; Myocardial Ischemia; Myocardial Reperfusion Injury; Peroxides; Rats; Rats, Sprague-Dawley; Resveratrol; Stilbenes; Wine | 1999 |
Myocardial protection by protykin, a novel extract of trans-resveratrol and emodin.
Topics: Animals; Antioxidants; Blood Pressure; Coronary Vessels; Emodin; Fluoresceins; Free Radical Scavengers; Gamma Rays; Hydroxyl Radical; Male; Malondialdehyde; Myocardial Infarction; Myocardial Ischemia; Oxidative Stress; Peroxides; Polygonaceae; Rats; Rats, Sprague-Dawley; Reperfusion Injury; Resveratrol; Stilbenes | 2000 |
Does resveratrol induce pharmacological preconditioning?
Topics: Adenosine; Animals; Antioxidants; Cardiovascular Physiological Phenomena; Heart; Ischemic Preconditioning, Myocardial; Male; Muscle Contraction; Myocardial Infarction; Myocardial Ischemia; Myocardium; Phosphates; Phosphorylation; Rats; Rats, Sprague-Dawley; Recovery of Function; Regional Blood Flow; Reperfusion Injury; Resveratrol; Stilbenes | 2000 |
Cardioprotective effect of resveratrol, a natural antioxidant derived from grapes.
Topics: Analysis of Variance; Animals; Antioxidants; Blood Pressure; Chi-Square Distribution; Free Radical Scavengers; Heart Rate; L-Lactate Dehydrogenase; Male; Myocardial Ischemia; Myocardial Reperfusion Injury; Nitric Oxide; Rats; Rats, Sprague-Dawley; Resveratrol; Statistics, Nonparametric; Stilbenes; Tachycardia, Ventricular; Ventricular Fibrillation | 2000 |
The protective effect of resveratrols on ischaemia-reperfusion injuries of rat hearts is correlated with antioxidant efficacy.
Topics: Animals; Biphenyl Compounds; Disease Models, Animal; Free Radical Scavengers; Humans; Lipoproteins, LDL; Male; Myocardial Ischemia; Oxidation-Reduction; Picrates; Protective Agents; Rats; Rats, Inbred WKY; Reperfusion Injury; Resveratrol; Stilbenes; Superoxides | 2002 |
Pharmacological preconditioning with resveratrol: role of nitric oxide.
Topics: Animals; Apoptosis; Enzyme Inhibitors; Gene Expression; Guanidines; Heart Ventricles; Ischemic Preconditioning; Malondialdehyde; Myocardial Infarction; Myocardial Ischemia; Myocardial Reperfusion Injury; Myocardium; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Rats; Rats, Sprague-Dawley; Resveratrol; RNA, Messenger; Stilbenes | 2002 |